Business Wire

DaTSCAN™ (Ioflupane I 123 Injection) SPECT Imaging Impacts the Diagnosis and Clinical Management of Patients with Clinically Uncertain Parkinsonian Syndrome

DUBLIN--(BUSINESS WIRE)--GE Healthcare today presented the results of a randomised controlled study analyzing the effect of DaTSCAN™ (Ioflupane I 123 Injection) SPECT imaging in a group of adult ...
Medscape

FDA Approves DaTscan for Imaging of Dopamine Transporters

January 17, 2011 — GE Healthcare has announced Food and Drug Administration (FDA) approval of ioflupane iodine-123 injection (DaTscan), a contrast agent for use with single-photon emission computed ...
Monthly Prescribing Reference

DaTscan Available to Assess Parkinsonian Syndromes

GE Healthcare announced that DaTscan (Ioflupane I 123 Injection) is available for the detection of dopamine transporters (DaT) in the brains of adult patients with suspected Parkinsonian syndromes.
Monthly Prescribing Reference

DaTscan Approved for Use in Patients With Suspected Lewy Body Dementia

DaTscan is a radioactive diagnostic agent that works by binding reversibly to the human dopamine transporter (DaT) in the brain. The Food and Drug Administration (FDA) has expanded the approval of ...
The American Journal of Managed Care

Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imaging With Ioflupane I-123 Injection (DaTscanâ„¢)

Parkinson’s disease (PD), the second-most common neurodegenerative disease, is characterized by motor and nonmotor symptoms. PD is often misdiagnosed; inappropriate treatment due to misdiagnosis has ...
KING5

DAT-scan gives doctors aglimpse inside Parkinson's brain

William Tank Hill used to be a professional welterweight fighter. Today he's fighting Parkinson's disease. Debora Bergstrom has it, too. The mother of three battles tremors, balance problems and ...